Praxis Precision Medicines, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 123.28 million compared to USD 214.03 million a year ago. Basic loss per share from continuing operations was USD 18.69 compared to USD 69.65 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.78 USD | -2.62% | -10.56% | +118.94% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+118.94% | 835M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- PRAX Stock
- News Praxis Precision Medicines, Inc.
- Praxis Precision Medicines, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023